Chairman and chief executive officer Robert A. Bradway will lead the discussion alongside members of the senior management team. The session will be broadcast live via the internet, providing access to investors, media representatives, and the general public.

Interested parties can access the audio stream through the Investor Relations Events Calendar on the company’s website. The presentation will remain available for replay for at least 90 days following the event. Based in Thousand Oaks, California, the biotechnology firm continues to manage a portfolio focused on oncology, inflammatory conditions, and cardiovascular health as part of its position within the Dow Jones Industrial Average.